Modern Retina Spring 2023
The sharing of data between ophthalmologists and optometrists ultimately can lead to earlier diagnosis and better results for patients.
Imaging biomarkers are useful to determine the degree of EZ attenuation in the fovea.
Industry leaders look at what’s in the therapeutic delivery pipeline for these disorders.
Physicians should consider hydrodynamic cavitation when performing this procedure.
Examining an intraocular implant that can sharpen vision for patients as disease progresses.
Advertisement
Advertisement
Trending on Modern Retina
1
Nanoscope Therapeutics releases positive long-term safety results from EXTEND study
2
Q&A: Sharon Fekrat discusses retinal manifestations of antipsychotic medications
3
Navigating the Gray Zone in MacTel Type 2: When to Treat Early or Advanced Disease
4
Real-World Insights From Diagnosis to Treatment in Macular Telangiectasia Type 2 Care
5
